CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 47.06%

Compliant submissions 8

Incompliant submissions 9

Total trials 17

My Organizations' Clinical Trials

Showing 125 of 867 entries

View as:

Voice-Activated Technology to Improve Mobility & Reduce Health Disparities (EngAGE)

Phase: N/A Priority: Normal

NCT ID: NCT05337514 Org: User:

Start: 10/26/22 End: 06/30/26 Due: 06/30/27

Posterior Rectus Sheath Hiatal Augmentation in Paraesophageal Hernia Repair

Phase: N/A Priority: Normal

NCT ID: NCT06551077 Org: User:

Start: 05/15/24 End: 05/31/29 Due: 05/31/30

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal

NCT ID: NCT00590681 Org: User:

Start: 02/28/07 End: 09/30/14 Due: 09/30/15

Achieving Routine Intervention and Screening for Emotional Health

Phase: N/A Priority: Normal

NCT ID: NCT06887049 Org: User:

Start: 05/31/26 End: 10/31/27 Due: 10/31/28

Communication Bridge 2

Phase: N/A Priority: Normal

NCT ID: NCT03371706 Org: User:

Start: 04/03/18 End: 03/23/23 Due: 03/23/24

Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

Phase: N/A Priority: Normal

NCT ID: NCT05988658 Org: User:

Start: 01/05/24 End: 03/01/28 Due: 03/01/29

Alcohol, Behavior, and Brain Imaging

Phase: N/A Priority: Normal

NCT ID: NCT03930446 Org: User:

Start: 01/01/16 End: 05/30/19 Due: 05/30/20

Development and Validation of a Tool to Measure Hand-off Quality

Phase: N/A Priority: Normal

NCT ID: NCT01059942 Org: User:

Start: 01/31/10 End: 12/31/12 Due: 12/31/13

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Phase: N/A Priority: Normal

NCT ID: NCT03225820 Org: User:

Start: 11/09/17 End: 08/31/25 Due: 08/31/26

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

Phase: N/A Priority: Normal

NCT ID: NCT02969837 Org: User:

Start: 07/10/17 End: 03/31/29 Due: 03/31/30

Inositol in Trichotillomania

Phase: N/A Priority: Normal

NCT ID: NCT01875445 Org: User:

Start: 05/31/13 End: 05/31/16 Due: 05/31/17

Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03203304 Org: User:

Start: 08/25/17 End: 03/13/19 Due: 03/13/20

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Phase: N/A Priority: Normal

NCT ID: NCT00943293 Org: User:

Start: 05/31/03 End: 01/31/12 Due: 01/31/13

Non-cancer Pain and Cognitive Impairment: A Disabling Relationship

Phase: N/A Priority: Normal

NCT ID: NCT01264965 Org: User:

Start: 01/31/11 End: 02/28/14 Due: 02/28/15

N2O for Acute Suicidality and Depression in the ED

Phase: N/A Priority: Normal

NCT ID: NCT05710887 Org: User:

Start: 10/01/25 End: 10/01/27 Due: 10/01/28

Single Shot vs Continuous Interscalene Block for Rotator Cuff Repair

Phase: N/A Priority: Normal

NCT ID: NCT01122745 Org: User:

Start: 08/31/10 End: 10/31/13 Due: 10/31/14

Comparison of Pain Relief After Non Stimulating Interscalene Catheter Placement vs Stimulating Catheter Placement in Total Shoulder Arthroplasty.

Phase: N/A Priority: Normal

NCT ID: NCT01122732 Org: User:

Start: 08/31/10 End: 09/30/15 Due: 09/30/16

Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03223155 Org: User:

Start: 09/07/17 End: 12/31/27 Due: 12/31/28

Topical Allstate and Nasal Allergen Challenge

Phase: N/A Priority: Normal

NCT ID: NCT01231724 Org: User:

Start: 11/30/11 End: 04/30/12 Due: 04/30/13

Babies' Expectations About Racial Interactions

Phase: N/A Priority: Normal

NCT ID: NCT05324007 Org: User:

Start: 09/01/21 End: 03/27/22 Due: 03/27/23

In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01236300 Org: User:

Start: 07/31/10 End: 05/31/12 Due: 05/31/13

Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal

NCT ID: NCT02573363 Org: User:

Start: 10/07/15 End: 05/03/19 Due: 05/03/20

A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy

Phase: N/A Priority: Normal

NCT ID: NCT03238638 Org: User:

Start: 09/30/18 End: 12/31/20 Due: 12/31/21

Nesiritide in Chronic Heart Failure

Phase: N/A Priority: Normal

NCT ID: NCT00145873 Org: User:

Start: 08/31/03 End: 09/30/06 Due: 09/30/07

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00026377 Org: User:

Start: 11/30/01 End: 04/30/03 Due: 04/30/04

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities (EngAGE)	NCT05337514	University of Chicago	user2@example.com	None	2022-10-26	2026-06-30	2027-06-30	-	-	2025-07-14
Posterior Rectus Sheath Hiatal Augmentation in Paraesophageal Hernia Repair	NCT06551077	University of Chicago	user2@example.com	None	2024-05-15	2029-05-31	2030-05-31	-	-	2025-07-14
Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme	NCT00590681	University of Chicago	user2@example.com	None	2007-02-28	2014-09-30	2015-09-30	-	-	2025-07-14
Achieving Routine Intervention and Screening for Emotional Health	NCT06887049	University of Chicago	user2@example.com	None	2026-05-31	2027-10-31	2028-10-31	-	-	2025-07-14
Communication Bridge 2	NCT03371706	University of Chicago	user2@example.com	None	2018-04-03	2023-03-23	2024-03-23	-	-	2025-07-14
Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients	NCT05988658	University of Chicago	user2@example.com	None	2024-01-05	2028-03-01	2029-03-01	-	-	2025-07-14
Alcohol, Behavior, and Brain Imaging	NCT03930446	University of Chicago	user2@example.com	None	2016-01-01	2019-05-30	2020-05-30	-	-	2025-07-14
Development and Validation of a Tool to Measure Hand-off Quality	NCT01059942	University of Chicago	user2@example.com	None	2010-01-31	2012-12-31	2013-12-31	-	-	2025-07-14
Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities	NCT03225820	University of Chicago	user2@example.com	None	2017-11-09	2025-08-31	2026-08-31	-	-	2025-07-14
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma	NCT02969837	University of Chicago	user2@example.com	None	2017-07-10	2029-03-31	2030-03-31	-	-	2025-07-14
Inositol in Trichotillomania	NCT01875445	University of Chicago	user2@example.com	None	2013-05-31	2016-05-31	2017-05-31	-	-	2025-07-14
Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer	NCT03203304	University of Chicago	user2@example.com	None	2017-08-25	2019-03-13	2020-03-13	-	-	2025-07-14
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies	NCT00943293	University of Chicago	user2@example.com	None	2003-05-31	2012-01-31	2013-01-31	-	-	2025-07-14
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship	NCT01264965	University of Chicago	user2@example.com	None	2011-01-31	2014-02-28	2015-02-28	-	-	2025-07-14
N2O for Acute Suicidality and Depression in the ED	NCT05710887	University of Chicago	user2@example.com	None	2025-10-01	2027-10-01	2028-10-01	-	-	2025-07-14
Single Shot vs Continuous Interscalene Block for Rotator Cuff Repair	NCT01122745	University of Chicago	user2@example.com	None	2010-08-31	2013-10-31	2014-10-31	-	-	2025-07-14
Comparison of Pain Relief After Non Stimulating Interscalene Catheter Placement vs Stimulating Catheter Placement in Total Shoulder Arthroplasty.	NCT01122732	University of Chicago	user2@example.com	None	2010-08-31	2015-09-30	2016-09-30	-	-	2025-07-14
Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer	NCT03223155	University of Chicago	user2@example.com	None	2017-09-07	2027-12-31	2028-12-31	-	-	2025-07-14
Topical Allstate and Nasal Allergen Challenge	NCT01231724	University of Chicago	user2@example.com	None	2011-11-30	2012-04-30	2013-04-30	-	-	2025-07-14
Babies' Expectations About Racial Interactions	NCT05324007	University of Chicago	user2@example.com	None	2021-09-01	2022-03-27	2023-03-27	-	-	2025-07-14
In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors	NCT01236300	University of Chicago	user2@example.com	None	2010-07-31	2012-05-31	2013-05-31	-	-	2025-07-14
Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia	NCT02573363	University of Chicago	user2@example.com	None	2015-10-07	2019-05-03	2020-05-03	-	-	2025-07-14
A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy	NCT03238638	University of Chicago	user2@example.com	None	2018-09-30	2020-12-31	2021-12-31	-	-	2025-07-14
Nesiritide in Chronic Heart Failure	NCT00145873	University of Chicago	user2@example.com	None	2003-08-31	2006-09-30	2007-09-30	-	-	2025-07-14
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer	NCT00026377	University of Chicago	user2@example.com	None	2001-11-30	2003-04-30	2004-04-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance